chlorhexidine gluconate and isopropyl alcohol
CHLORAPREP ONE-STEP FREPP (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2000.
Drug data last refreshed 22h ago · AI intelligence enriched 5d ago
CHLORAPREP ONE-STEP FREPP is a topical antiseptic sponge combining chlorhexidine gluconate and isopropyl alcohol, designed to reduce bacterial contamination at surgical and procedural sites. It is applied directly to skin prior to invasive procedures to prevent infection. The dual-agent formulation provides rapid antimicrobial activity through the synergistic action of chlorhexidine's persistent bacterial suppression and isopropyl alcohol's rapid germicidal effect.
Product is within 0.6 years of loss of exclusivity, signaling a transition from peak commercialization to generic erosion and likely consolidation of brand team resources.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CHLORAPREP ONE-STEP FREPP at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Patent cliff in less than a year — expect lifecycle management and generic defense hiring
Working on CHLORAPREP ONE-STEP FREPP in 2025 means joining a mature, declining franchise with minimal growth trajectory and significant risk of rapid displacement. Career opportunities are concentrated in defensive commercialization, pricing strategy, and supply-chain optimization rather than innovation or expansion.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo